New Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada

Developed by i3 Innovus for the PMPRB*,

Learn more about:

• Performing budget impact analyses using the recommended analytic framework
• Recommended inputs, data sources, and analytic methods for budget impact models
• Submitting budget impact analyses with the key information needed by public drug plan managers
• Using the interactive budget impact model template that accompanies the guidelines.

Click here for Canada’s NEW BIA Guidelines and interactive BIM template